诺和诺德（Novo Nordisk） (NVO.US)今日宣布，欧洲药品管理局（EMA）人用药品委员会（CHMP）已对其重磅疗法Ozempic（司美格鲁肽，semaglutide）更新标签纳入降低肾病相关事件风险的信息发布了积极意见，该决定基于FLOW肾脏结局试验的积极数据。 根据新闻稿 ， Ozempic将可能成为可降低2型糖尿病伴慢性肾病（CKD）成人患者肾病进展风险的首个GLP-1受体激动剂 ...

The 9th generation Toyota Camry boasts an all-new design language along with a premium interior and a 2.5-litre petrol hybrid ...

Novo Nordisk's Ozempic gains positive EMA opinion for label update after FLOW trial data show significant kidney and ...

The 9th generation Toyota Camry boasts an all-new design language along with a premium interior and a 2.5-litre petrol hybrid ...

The EMA approved a kidney disease–related label expansion for the blockbuster GLP-1 drug after a study showed reduced risk of ...

The presentation highlights XORTX recent pioneering discoveries in the field of Autosomal Dominant Polycystic Kidney Disease ...

New-gen Toyota Camry launched at 48 lakh, will rival Skoda Superb. 2024 Honda Amaze gets CNG option. The 2024 Honda Amaze was ...

基于共识，共建科学管理方案！相较于2020年版《中国2型糖尿病防治指南》[1]，我国成人糖尿病患病率已从11.2%上升至12.4%，其中2型糖尿病占据主要比例。尤为引人关注的是，这一患者群体中大约30%-40%面临发展为慢性肾脏病（CKD）的风险，而 ...

The Skoda Superb has more torque (320 Nm) and features a 7-speed DSG gearbox, which could provide a more engaging and dynamic ...

New Skoda Kodiaq in second generation guise will launch between April-June 2025; is expected to be offered in multiple trims.

Toyota Camry has only one direct rival in the Indian market in the form of Skoda rival which is priced Rs 54 lakh ...